Trial Profile
A study investigating efficacy and safety of everolimus in patients who received de novo orthotopic liver transplantation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Nov 2016
Price :
$35
*
At a glance
- Drugs Everolimus (Primary) ; Mycophenolate mofetil (Primary) ; Mycophenolate sodium (Primary) ; Steroids (Primary) ; Tacrolimus (Primary)
- Indications Liver transplant rejection
- Focus Therapeutic Use
- 16 Sep 2015 Results presented at the 17th Congress of the European Society for Organ Transplantation
- 17 Aug 2015 New trial record